World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26021
World Ranking
15091
National Ranking
192

Overview

Claude Schulman is affiliated with the Université Libre de Bruxelles in Belgium. Their research contributions are situated within the fields of Medicine and Health Professions, with a particular focus on Oncology, Surgery, and General Health Professions.

The scientist's work addresses key topics related to healthcare including the impacts of COVID-19, abdominal trauma and injuries, and healthcare cost, quality, and practices.

One of their published papers, titled "Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists", appeared in 2020 in the journal Urologic Oncology Seminars and Original Investigations. This paper has been cited multiple times and reflects Schulman's involvement in research at the intersection of clinical oncology and the effects of the COVID-19 pandemic.

  • Barak Rosenzweig
  • Axel Bex
  • Zohar Dotan
  • Mark Frydenberg
  • Laurence Klotz

These coauthors have collaborated with Schulman on research projects, indicating engagement with specialists in urologic oncology and related medical fields.

  • Urologic Oncology Seminars and Original Investigations

Publications have predominantly appeared in the journal Urologic Oncology Seminars and Original Investigations, marking this venue as a primary platform for disseminating their work.

Best Publications

  • Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Investigation, treatment and monitoring of late-onset hypogonadism in males

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Investigation, treatment and monitoring of late-onset hypogonadism in males

    Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre;Louis Gooren

  • ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

    Bob Djavan;Vincent Ravery;Alex Zlotta;Piotr Dobronski

  • Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

    Matthew R. Smith;Fairooz Kabbinavar;Fred Saad;Arif Hussain

  • Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial

    Michael A. Carducci;Robert J. Padley;Jurgen Breul;Nicholas J. Vogelzang

  • SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDY

    Bob Djavan;Matthias Waldert;Alexandre Zlotta;Piotr Dobronski

  • Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder?

    Piero Montorsi;Francesco Montorsi;Claude C. Schulman

  • Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature

    Vincenzo Scattoni;Alexandre Zlotta;Rodolfo Montironi;Claude Schulman

  • OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MEN

    Bob Djavan;Alexandre Zlotta;Mesut Remzi;Keywan Ghawidel

  • A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer

    Michael A. Carducci;Fred Saad;Per Anders Abrahamsson;David P. Dearnaley

  • Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations

    Christina Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann M. Behre

  • Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations

    Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre;Louis Gooren

  • Benign prostatic hyperplasia: A progressive disease of aging men

    Mark Emberton;Gerald L Andriole;Jean de la Rosette;Bob Djavan

  • Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases

    R. Bollens;M. Vanden Bossche;Th. Roumeguere;A. Damoun

  • 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer

    Claude C. Schulman;Frans M.J. Debruyne;Gerhard Forster;Francesco P. Selvaggi

  • Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)

    Paul P. Abrams;Claude Schulman;Sigmund Vaage

  • Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk.

    Thierry Roumeguere;Eric Wespes;Yvon Carpentier;Philippe Hoffmann

  • Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer†‡

    Joel B. Nelson;William Love;Joseph L. Chin;Fred Saad

Frequent Co-Authors

Alexandre R. Zlotta
Alexandre R. Zlotta University Health Network
Michael Marberger
Michael Marberger Medical University of Vienna
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Frederick C. W. Wu
Frederick C. W. Wu University of Manchester
Wolfgang Weidner
Wolfgang Weidner University of Giessen
John E. Morley
John E. Morley Saint Louis University
Ronald S. Swerdloff
Ronald S. Swerdloff Lundquist Institute
Eberhard Nieschlag
Eberhard Nieschlag University of Münster
Robert Kiss
Robert Kiss Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a medical career in the USA, you may want to consider alternative online degrees and career pathways that complement traditional medical studies. These options offer flexibility and cater to diverse interests within healthcare.

For those interested in healthcare leadership, online health administration programs prepare graduates for management roles in hospitals, clinics, and health systems. If you’re a registered nurse looking to advance, consider the bridging options available through asn to np programs, which streamline the path from associate to nurse practitioner.

Nutrition is a growing field, and the best online nutrition programs offer a science-based route to becoming a dietitian or nutritionist. Leadership at an executive level becomes possible with a Master of Health Administration—explore the top cahme-accredited mha programs to elevate your credentials.

These online pathways provide flexible learning, open more career doors, and give you the skills to thrive across the healthcare sector.

Best Scientists Citing Claude Schulman

Trending Scientists